June 17, 2020
1 min read
Save
VICTORIA
Issue: June 2020
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Vericiguat (Merck/Bayer) vs. placebo for prevention of CV death or HF hospitalization in patients with HFrEF.